PetIQ, Inc. operates as a pet medication and wellness company. More Details
Reasonable growth potential and fair value.
Share Price & News
How has PetIQ's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: PETQ has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: PETQ exceeded the US Healthcare industry which returned 22.3% over the past year.
Return vs Market: PETQ exceeded the US Market which returned 17.2% over the past year.
Price Volatility Vs. Market
How volatile is PetIQ's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StHow Is PetIQ's (NASDAQ:PETQ) CEO Compensated?
1 month ago | Simply Wall StThe Executive Vice President of Products Division of PetIQ, Inc. (NASDAQ:PETQ), Michael Smith, Just Sold 100% Of Their Holding
1 month ago | Simply Wall StIntroducing PetIQ (NASDAQ:PETQ), A Stock That Climbed 42% In The Last Three Years
Is PetIQ undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: PETQ ($32.92) is trading below our estimate of fair value ($84.16)
Significantly Below Fair Value: PETQ is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: PETQ is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.
PE vs Market: PETQ is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate PETQ's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: PETQ is good value based on its PB Ratio (2.5x) compared to the US Healthcare industry average (2.9x).
How is PetIQ forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PETQ is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).
Earnings vs Market: PETQ is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: PETQ's is expected to become profitable in the next 3 years.
Revenue vs Market: PETQ's revenue (13% per year) is forecast to grow faster than the US market (9.9% per year).
High Growth Revenue: PETQ's revenue (13% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PETQ's Return on Equity is forecast to be high in 3 years time
How has PetIQ performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PETQ is currently unprofitable.
Growing Profit Margin: PETQ is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: PETQ is unprofitable, and losses have increased over the past 5 years at a rate of 50% per year.
Accelerating Growth: Unable to compare PETQ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PETQ is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (31.1%).
Return on Equity
High ROE: PETQ has a negative Return on Equity (-7.47%), as it is currently unprofitable.
How is PetIQ's financial position?
Financial Position Analysis
Short Term Liabilities: PETQ's short term assets ($383.2M) exceed its short term liabilities ($125.2M).
Long Term Liabilities: PETQ's short term assets ($383.2M) exceed its long term liabilities ($378.7M).
Debt to Equity History and Analysis
Debt Level: PETQ's debt to equity ratio (99.2%) is considered high.
Reducing Debt: PETQ's debt to equity ratio has increased from 49.4% to 99.2% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PETQ has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if PETQ has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is PetIQ current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate PETQ's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PETQ's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if PETQ's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PETQ's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of PETQ's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
McCord Christensen (48 yo)
Mr. McCord Christensen serves as Chief Executive Officer of PetIQ, Inc. Mr. Christensen is the Co-Founder of PetIQ, Inc. in 2010. He gained extensive retail and management experience working at Albertson’s ...
CEO Compensation Analysis
Compensation vs Market: McCord's total compensation ($USD1.90M) is below average for companies of similar size in the US market ($USD3.03M).
Compensation vs Earnings: McCord's compensation has been consistent with company performance over the past year.
|Chairman of the Board & CEO||10.67yrs||US$1.90m||0.0062% |
|Chief Financial Officer||6.67yrs||US$1.27m||0.38% |
|Executive Vice President of Products Division||1.17yrs||US$2.38m||0% |
|General Counsel & Secretary||1.5yrs||no data||0.0059% |
|Senior VP & Chief Medical Officer||0.50yr||no data||no data|
Experienced Management: PETQ's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
|Chairman of the Board & CEO||10.67yrs||US$1.90m||0.0062% |
|Lead Independent Director||3.17yrs||US$65.00k||0.0072% |
|Independent Director||1.08yrs||US$68.71k||0.0019% |
|Independent Director||3.17yrs||US$58.45k||0.15% |
|Independent Director||3.17yrs||US$53.01k||0.57% |
|Independent Director||2.5yrs||US$53.01k||0.013% |
Experienced Board: PETQ's board of directors are considered experienced (3.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: PETQ insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
PetIQ, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: PetIQ, Inc.
- Ticker: PETQ
- Exchange: NasdaqGS
- Founded: 2010
- Industry: Health Care Distributors
- Sector: Healthcare
- Implied Market Cap: US$936.585m
- Market Cap: US$820.304m
- Shares outstanding: 28.57m
- Website: https://www.petiq.com
Number of Employees
- PetIQ, Inc.
- 923 South Bridgeway Place
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|39L||DB (Deutsche Boerse AG)||Yes||Class A Common Stock||DE||EUR||Jul 2017|
|PETQ||NasdaqGS (Nasdaq Global Select)||Yes||Class A Common Stock||US||USD||Jul 2017|
PetIQ, Inc. operates as a pet medication and wellness company. It operates through two segments, Products and Services. The company offers prescription pet medications, including products for arthritis, th ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/30 23:32|
|End of Day Share Price||2020/09/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.